XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 40.54 million as of May 13, 2025. Its market cap has decreased by -27.76% in one year.

Market Cap

40.54M

Enterprise Value

36.88M

Revenue

1.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

4.60

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 40.54M, a decrease of -94.97%. That is a compound annual growth rate of -14.07%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	39.66M	-51.35%
Dec 31, 2024	81.53M	327.50%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	68.75B
Danel (Adir Yeoshua)	2.36B
Kamada	1.45B
Bait Bakfar	1.14B
Novolog (Pharm-Up 1966)	794.87M
Ilex Medical	689.63M
SofWave Medical	646.14M
BrainsWay	599.27M

Market Cap Rankings